A real-world economic analysis of the cost implications of switching from sevelamer hydrochloride to lanthanum carbonate in the bundled reimbursement scheme
May 1, 2013, 00:00
10.1016/j.jval.2013.03.941
https://www.valueinhealthjournal.com/article/S1098-3015(13)01012-7/fulltext
Title :
A real-world economic analysis of the cost implications of switching from sevelamer hydrochloride to lanthanum carbonate in the bundled reimbursement scheme
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01012-7&doi=10.1016/j.jval.2013.03.941
First page :
A187
Section Title :
Health Services
Open access? :
No
Section Order :
495